Form 4 for ANVS Annovis Bio, Inc.
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-13 · accession 0001104659-25-059897 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-16 | 2025-06-13 | ANVS | Hoffman Michael B | Dir | A - Grant | $2.80 | +25.0K | 1.45M | +2% | +$70.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-13 | A | A | 1 | $2.83 | 1,446,284 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-13 | A | A | 25,000 | $2.80 | 1,446,283 | D | — | — |